Ping Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ping Wu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Annamaria Brioli
Clinic for Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School , Hannover
1 shared publication - Charlotte Pawlyn
The Institute of Cancer Research, London, UK
1 shared publication - Faith E. Davies
Perlmutter Cancer Center, NYU Langone Health, New York, NY
1 shared publication Fiona M Ross
Wessex Regional Genetics Lab., University of Southampton, Salisbury, United Kingdom
1 shared publication- Gareth John Morgan
Multiple Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
1 shared publication - Graham Hunter Jackson
Department of Haematology, University of Newcastle, Newcastle upon Tyne, United Kingdom
1 shared publication
Latest Publications
- Open Access
Variation and interaction of distinct subgenomes contribute to growth diversity in intergeneric hybrid fish
Intergeneric hybridization greatly reshapes regulatory interactions among allelic and non-allelic genes. However, their effects on growth diversity remain poorly understood in animals. In this study, we conducted whole-genome sequencing and mRNA-seq analyses in diverse hybrid varieties resulting from the intergeneric hybridization of goldfish ( Carassius auratus red var.) and common carp ( Cyprinus carpio ). These hybrid individuals were characterized by distinct mitochondrial genomes and copy number variations. Through a weighted gene correlation network analysis, we identified 3693 genes as candidate growth-regulated genes. Among them, the expression of 3672 genes in subgenome R (originating from goldfish) displayed negative correlations with growth rate, whereas 20 genes in subgenome C (originating from common carp) exhibited positive correlations. Notably, we observed intriguing patterns in the expression of slc2a12 in subgenome C, showing opposite correlations with body weight that changed with water temperatures, suggesting differential interactions between feeding activity and weight gain in response to seasonal changes for hybrid animals. In 40.31% of alleles, we observed dominant trans -regulatory effects in the regulatory interaction between distinct alleles from subgenomes R and C. Integrating analyses of allelic-specific expression and DNA methylation data revealed that the influence of DNA methylation on both subgenomes shapes the relative contribution of allelic expression to the growth rate. These findings provide novel insights into the interaction of distinct subgenomes that underlie heterosis in growth traits and contribute to a better understanding of multiple-allele traits in animals.
Open AccessVariation and interaction of distinct subgenomes contribute to growth diversity in intergeneric hybrid fish
Intergeneric hybridization greatly reshapes regulatory interactions among allelic and non-allelic genes. However, their effects on growth diversity remain poorly understood in animals. In this study, we conducted whole-genome sequencing and mRNA-seq analyses in diverse hybrid varieties resulting from the intergeneric hybridization of goldfish ( Carassius auratus red var.) and common carp ( Cyprinus carpio ). These hybrid individuals were characterized by distinct mitochondrial genomes and copy number variations. Through a weighted gene correlation network analysis, we identified 3693 genes as candidate growth-regulated genes. Among them, the expression of 3672 genes in subgenome R (originating from goldfish) displayed negative correlations with growth rate, whereas 20 genes in subgenome C (originating from common carp) exhibited positive correlations. Notably, we observed intriguing patterns in the expression of slc2a12 in subgenome C, showing opposite correlations with body weight that changed with water temperatures, suggesting differential interactions between feeding activity and weight gain in response to seasonal changes for hybrid animals. In 40.31% of alleles, we observed dominant trans -regulatory effects in the regulatory interaction between distinct alleles from subgenomes R and C. Integrating analyses of allelic-specific expression and DNA methylation data revealed that the influence of DNA methylation on both subgenomes shapes the relative contribution of allelic expression to the growth rate. These findings provide novel insights into the interaction of distinct subgenomes that underlie heterosis in growth traits and contribute to a better understanding of multiple-allele traits in animals.
- 1 June 2022
- Published by Wiley in Journal of Fish Biology
- Vol. 101 (1) , 168-178
Effect of starvation and refeeding on reactive oxygen species, autophagy and oxidative stress in Chinese perch (Siniperca chuatsi) muscle growth
In skeletal muscle, autophagy regulates the development and growth of muscle fibres and maintains the normal muscle metabolism. Under starvation and refeeding conditions, the effect of reactive oxygen species (ROS) levels on skeletal muscle autophagy is still unclear, although the excessive accumulation of ROS has been shown to increase autophagy in cells. The purpose of this study was to explore the effects of starvation and diet after starvation on the autophagy of adult Chinese perch muscle, and to determine the level of ROS in the muscle. We performed zero (Normal control), three and seven starvation treatments on adult Chinese perch, and returned to normal feeding for 3 days after starvation for 7 days. In the muscles of the adult Chinese perch muscle after 3 days of starvation, the autophagy marker protein LC3 and the number of autophagosomes remained basically the same as in the normal feeding situation. However, on starvation for 7 days, the mitochondrial autophagy was sensitive and the number of autophagosomes increased, but the antioxidant‐related molecules (malondialdehyde, catalase, glutathione S‐transferase, glutathione and anti‐superoxide anion) decreased and the accumulation of ROS was obvious. In addition, the extended starvation time also increased the level of LC3 protein. However, by refeeding after starvation this nutritional stress resulted in a decrease in ROS levels and a partial restoration of antioxidant enzyme activity. Our data show that in the adult Chinese perch muscle, starvation could reduce the antioxidant activity through the accumulation of ROS, and that the number of autophagosomes continues to increase. Refeeding after starvation could effectively compensate for the level of ROS, and restore the mRNA abundance of antioxidant genes and the activity of antioxidant enzymes to reduce autophagy and improve feed efficiency. Further research should optimize starvation conditions to reduce autophagy in muscles and maintain normal muscle metabolism.
- 1 June 2022
- Published by Wiley in Journal of Fish Biology
- Vol. 101 (1) , 168-178
Effect of starvation and refeeding on reactive oxygen species, autophagy and oxidative stress in Chinese perch (Siniperca chuatsi) muscle growth
In skeletal muscle, autophagy regulates the development and growth of muscle fibres and maintains the normal muscle metabolism. Under starvation and refeeding conditions, the effect of reactive oxygen species (ROS) levels on skeletal muscle autophagy is still unclear, although the excessive accumulation of ROS has been shown to increase autophagy in cells. The purpose of this study was to explore the effects of starvation and diet after starvation on the autophagy of adult Chinese perch muscle, and to determine the level of ROS in the muscle. We performed zero (Normal control), three and seven starvation treatments on adult Chinese perch, and returned to normal feeding for 3 days after starvation for 7 days. In the muscles of the adult Chinese perch muscle after 3 days of starvation, the autophagy marker protein LC3 and the number of autophagosomes remained basically the same as in the normal feeding situation. However, on starvation for 7 days, the mitochondrial autophagy was sensitive and the number of autophagosomes increased, but the antioxidant‐related molecules (malondialdehyde, catalase, glutathione S‐transferase, glutathione and anti‐superoxide anion) decreased and the accumulation of ROS was obvious. In addition, the extended starvation time also increased the level of LC3 protein. However, by refeeding after starvation this nutritional stress resulted in a decrease in ROS levels and a partial restoration of antioxidant enzyme activity. Our data show that in the adult Chinese perch muscle, starvation could reduce the antioxidant activity through the accumulation of ROS, and that the number of autophagosomes continues to increase. Refeeding after starvation could effectively compensate for the level of ROS, and restore the mRNA abundance of antioxidant genes and the activity of antioxidant enzymes to reduce autophagy and improve feed efficiency. Further research should optimize starvation conditions to reduce autophagy in muscles and maintain normal muscle metabolism.
- Open Access
- 16 November 2012
- Published by American Society of Hematology in Blood
- Vol. 120 (21) , 199
The Impact of Thalidomide Maintenance Therapy Varies Dependent Upon Biological Risk Grouping
Abstract 199 Recent studies have shown a clinical benefit for maintenance therapy in myeloma, however, the impact may vary dependent upon the underlying biology of the disease. An important question is whether maintenance can facilitate progression of high risk disease. Genetic alterations, such as t(4;14), del(17p) and +1q, can be used to define different biological behaviours, and we have shown that the presence of more than one adverse iFISH lesion can define a group of patients with very aggressive disease. We have studied the impact of thalidomide maintenance dependent upon risk status in the MRC IX study. The trial comprised an intensive and a non-intensive pathway based on patient eligibility for autologous transplant. Patients were subsequently randomized to receive maintenance thalidomide versus no maintenance. iFISH results with a complete data set for adverse IgH translocations, +(1)(q21) and del(17)(p13) were available in 368 cases. Patients were characterized as having standard (SR), high (HR) or ultra-high risk (UHR) disease based on the number of co segregating iFISH lesions (0, 1 or >1). We also looked at defined biological subtype of disease: t(4;14), t(11;14) and hyperdiploidy were considered in isolation or plus an additional adverse lesion. In isolation del(13q) was not of prognostic significance and was not considered in the analysis. Progression free survival (PFS) and overall survival (OS) were calculated from maintenance randomization. Results are summarized in Table 1. On overall population the median PFS and OS for maintenance and for control arm were 19.7 vs 14.7 months (p=0.066) and 37.4 vs 42.9 months (p=0.168), respectively. In the control arm the median PFS of SR, HR and UHR was of 20.2; 13.4; 6.7 (p=0.008) and the median OS was of 48.2; 44.7; 26.8 months (p=0.014), respectively. In the maintenance arm the median PFS was 29.6; 11.7; 6.5 (p=0.008) and for OS was 48.6; 29.6; 23.5 months (p=0.000). Compared to the control arm, SR patients receiving maintenance had a longer PFS with a similar OS, while the HR patients had similar PFS yet impaired OS. The outcome of the UHR was poor irrespective of whether maintenance was given or not. The outcome of t(4;14) was unfavorable in the control arm. Thalidomide maintenance improved the outcome of patients t(4;14) negative (n=325) or with t(4;14) in isolation (n=13), with a trend towards a better PFS; in particular, for t(4;14) positive patients, median PFS for maintenance and controls were 24.6 vs 7.2 months, respectively. OS was similar between treatment arms. t(4;14) plus an additional lesion (n=30) identified a group with a particularly poor outcome irrespective of whether maintenance was given or not. t(11;14) positive patients (n=54) had a favorable outcome; thalidomide maintenance did not discernibly affect PFS and OS. The impact of maintenance was similar whether the translocation was present in isolation (n=39) or in association with another lesion (n=15). The outcome of hyperdiploid patients (n=134) was favorable with a median PFS and OS of 21.2 and 44.4 months, respectively; cases receiving maintenance had an improved PFS (p=0.003), with similar OS. Low risk FISH with hyperdiploidy receiving maintenance had the best PFS and OS (median 36.7 and 50.1 months respectively). Hyperdiploidy associated with another lesion (n=85) behaved as the HR group. Maintenance thalidomide is effective in prolonging PFS in biological LR patients and in patients with t(4;14) in isolation. Conversely, in patients with biologically defined HR disease maintenance thalidomide may not impair PFS but can impair OS. The outcome of cases with very aggressive disease (UHR or t(4;14) plus an additional lesion) is governed by factor others than thalidomide maintenance.
- 16 November 2012
- Published by American Society of Hematology in Blood
- Vol. 120 (21) , 199
Open AccessThe Impact of Thalidomide Maintenance Therapy Varies Dependent Upon Biological Risk Grouping
Abstract 199 Recent studies have shown a clinical benefit for maintenance therapy in myeloma, however, the impact may vary dependent upon the underlying biology of the disease. An important question is whether maintenance can facilitate progression of high risk disease. Genetic alterations, such as t(4;14), del(17p) and +1q, can be used to define different biological behaviours, and we have shown that the presence of more than one adverse iFISH lesion can define a group of patients with very aggressive disease. We have studied the impact of thalidomide maintenance dependent upon risk status in the MRC IX study. The trial comprised an intensive and a non-intensive pathway based on patient eligibility for autologous transplant. Patients were subsequently randomized to receive maintenance thalidomide versus no maintenance. iFISH results with a complete data set for adverse IgH translocations, +(1)(q21) and del(17)(p13) were available in 368 cases. Patients were characterized as having standard (SR), high (HR) or ultra-high risk (UHR) disease based on the number of co segregating iFISH lesions (0, 1 or >1). We also looked at defined biological subtype of disease: t(4;14), t(11;14) and hyperdiploidy were considered in isolation or plus an additional adverse lesion. In isolation del(13q) was not of prognostic significance and was not considered in the analysis. Progression free survival (PFS) and overall survival (OS) were calculated from maintenance randomization. Results are summarized in Table 1. On overall population the median PFS and OS for maintenance and for control arm were 19.7 vs 14.7 months (p=0.066) and 37.4 vs 42.9 months (p=0.168), respectively. In the control arm the median PFS of SR, HR and UHR was of 20.2; 13.4; 6.7 (p=0.008) and the median OS was of 48.2; 44.7; 26.8 months (p=0.014), respectively. In the maintenance arm the median PFS was 29.6; 11.7; 6.5 (p=0.008) and for OS was 48.6; 29.6; 23.5 months (p=0.000). Compared to the control arm, SR patients receiving maintenance had a longer PFS with a similar OS, while the HR patients had similar PFS yet impaired OS. The outcome of the UHR was poor irrespective of whether maintenance was given or not. The outcome of t(4;14) was unfavorable in the control arm. Thalidomide maintenance improved the outcome of patients t(4;14) negative (n=325) or with t(4;14) in isolation (n=13), with a trend towards a better PFS; in particular, for t(4;14) positive patients, median PFS for maintenance and controls were 24.6 vs 7.2 months, respectively. OS was similar between treatment arms. t(4;14) plus an additional lesion (n=30) identified a group with a particularly poor outcome irrespective of whether maintenance was given or not. t(11;14) positive patients (n=54) had a favorable outcome; thalidomide maintenance did not discernibly affect PFS and OS. The impact of maintenance was similar whether the translocation was present in isolation (n=39) or in association with another lesion (n=15). The outcome of hyperdiploid patients (n=134) was favorable with a median PFS and OS of 21.2 and 44.4 months, respectively; cases receiving maintenance had an improved PFS (p=0.003), with similar OS. Low risk FISH with hyperdiploidy receiving maintenance had the best PFS and OS (median 36.7 and 50.1 months respectively). Hyperdiploidy associated with another lesion (n=85) behaved as the HR group. Maintenance thalidomide is effective in prolonging PFS in biological LR patients and in patients with t(4;14) in isolation. Conversely, in patients with biologically defined HR disease maintenance thalidomide may not impair PFS but can impair OS. The outcome of cases with very aggressive disease (UHR or t(4;14) plus an additional lesion) is governed by factor others than thalidomide maintenance.